Wednesday, March 18, 2026

We Are
New to The Street

New to The Street believe’s everyone has their own version of success. We exist to help people get their version of success, no matter what that is. Our core motivation is to inspire, innovate, and drive cultural impact.

hero image

Latest Videos

Latest videos from our channel

Check All Videos
Stardust Power Advances $500M Lithium Refinery Project in Oklahoma | 2025 Update

Stardust Power Advances $500M Lithium Refinery Project in Oklahoma | 2025 Update

2 hours ago
NRX Pharma Advances Toward FDA Approval for Preservative-Free Ketamine Drug

NRX Pharma Advances Toward FDA Approval for Preservative-Free Ketamine Drug

2 hours ago
Health In Tech Partners With Cyclum to Expand AI Insurtech Platform Capabilities

Health In Tech Partners With Cyclum to Expand AI Insurtech Platform Capabilities

2 hours ago

Meet the Companies

PetVivo Targets $40B Veterinary Market with Regenerative Joint Therapy and AI Vet Platform

PetVivo Targets $40B Veterinary Market with Regenerative Joint Therapy and AI Vet Platform

7 days ago
Floki Explains Meme Coin Evolution, Tokenization, and the Future of Web3 Innovation

Floki Explains Meme Coin Evolution, Tokenization, and the Future of Web3 Innovation

7 days ago
Stardust Power and HPB Explore U.S.–Germany Battery Innovation Partnership at New York Summit

Stardust Power and HPB Explore U.S.–Germany Battery Innovation Partnership at New York Summit

6 days ago

News Out

Latest news updates

Stardust Power Advances $500M Lithium Refinery Project in Oklahoma | 2025 Update

Stardust Power Advances $500M Lithium Refinery Project in Oklahoma | 2025 Update

2 hours ago
NRX Pharma Advances Toward FDA Approval for Preservative-Free Ketamine Drug

NRX Pharma Advances Toward FDA Approval for Preservative-Free Ketamine Drug

2 hours ago
Health In Tech Partners With Cyclum to Expand AI Insurtech Platform Capabilities

Health In Tech Partners With Cyclum to Expand AI Insurtech Platform Capabilities

2 hours ago
NRX Pharma Moves Closer to FDA Approval for NRX-100 With No New Trials Required

NRX Pharma Moves Closer to FDA Approval for NRX-100 With No New Trials Required

17 hours ago
NRX Pharmaceuticals Advances NRX-100 Toward FDA Approval With No New Trials Required

NRX Pharmaceuticals Advances NRX-100 Toward FDA Approval With No New Trials Required

1 day ago
ThinkEquity Appoints Veteran Trader Michael Messinger to Lead Fixed Income Desk | NewsOut

ThinkEquity Appoints Veteran Trader Michael Messinger to Lead Fixed Income Desk | NewsOut

2 days ago

Our Companies

Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo

What We Offer

Viable Choices

  • Commercial Quantity
  • Commercial Quality
  • Outdoor Advertising
  • Featured Broadcast
  • Availability & Opportunity
  • Value For Money

Brand Awareness

  • Brand Recognition
  • Unaided Awareness
  • Aided Awareness
  • Engagement
  • Community Growth
  • Global Reach

Strong Partnership

  • Managed Client Support
  • Client Service
  • Outdoor Advertising
  • Tools & Programs

User Experience

  • Seamless Interface
  • Fast Loading
  • Accessibility
  • Intuitive Design
  • Mobile Optimized

Content Value

  • Exclusive Material
  • High Relevance
  • Daily Updates
  • Curated Feeds
  • Expert Opinions

Community

  • Active Discussions
  • Networking Events
  • Member Support
  • Global Connection